AJP - Heart and Circulatory Physiology, Vol 267, Issue 3 912-H917, Copyright © 1994 by American Physiological Society

ARTICLES

Comparison of cardiovascular effects of mu- and delta-opioid receptor antagonists in dogs with congestive heart failure

N. Imai, M. Kashiki, P. D. Woolf and C. S. Liang
Department of Medicine, University of Rochester Medical Center, New York 14642.

We have shown previously that right heart failure (RHF) in dogs is associated with activated endogenous opiate systems, and that administration of the opioid receptor antagonist, naloxone, increases arterial pressure, cardiac contractile function and organ blood flows. To study whether the cardiovascular effects of naloxone are mediated via the mu- or delta-opioid receptors, we administered ICI-154,129, a delta-receptor antagonist, and naloxonazine, a mu-receptor antagonist, to 10 conscious dogs with RHF on 2 separate days. Like naloxone, ICI-154,129 increased mean aortic pressure, cardiac output, peak positive first derivative of left ventricular pressure, and blood flows to the myocardium, kidneys, splanchnic beds, and skeletal muscle. These changes were associated with increases in plasma epinephrine and norepinephrine. In contrast, naloxonazine had no effects on systemic hemodynamics, regional blood flow distribution, and plasma catecholamines in RHF. These findings suggest that the increased endogenous opioids during heart failure act on the delta-opioid receptors to decrease myocardial mechanical performance and alter regional blood flow distribution. Opioid receptor-blocking agents may exert beneficial cardiovascular effects in heart failure.

This article has been cited by other articles:

				T. P. Weber, C. Raufhake, M. A. Gro{beta}e Hartlage, N. Rolf, J. Stypmann, H. Van Aken, E. Berendes, and A. Mei{beta}ner Naloxone prevents increased atrial natriuretic peptide release during regional myocardial ischaemia and stunning in awake dogs Br. J. Anaesth., January 1, 2002; 88(1): 87 - 93. [Abstract] [Full Text] [PDF]

				T. P. Weber, J. Stypmann, A. Mei{beta}ner, M. Gro{beta}e Hartlage, H. Van Aken, and N. Rolf Naloxone improves functional recovery of myocardial stunning in conscious dogs through its action on the central nervous system Br. J. Anaesth., April 1, 2001; 86(4): 545 - 549. [Abstract] [Full Text] [PDF]

				B. A. Barron Cardiac Opioids Experimental Biology and Medicine, May 1, 2000; 224(1): 1 - 7. [Abstract] [Full Text]

				S. Pepe, R.-P. Xiao, C. Hohl, R. Altschuld, and E. G. Lakatta `Cross Talk' Between Opioid Peptide and Adrenergic Receptor Signaling in Isolated Rat Heart Circulation, April 15, 1997; 95(8): 2122 - 2129. [Abstract] [Full Text]

				R. Zimlichman, D. Gefel, H. Eliahou, Z. Matas, B. Rosen, S. Gass, C. Ela, Y. Eilam, Z. Vogel, and J. Barg Expression of Opioid Receptors During Heart Ontogeny in Normotensive and Hypertensive Rats Circulation, March 1, 1996; 93(5): 1020 - 1025. [Abstract] [Full Text]